Back to search

Lunac Therapeutics Limited

11317849

active
Private Limited Company
england wales
Companies House
Insolvency history
Health Score
53 / 100

Notable Risks

25/30
Filing
10/30
Financial
18/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)
  • Active insolvency proceedings (-20)
  • 1 outstanding charge (-2)

Details

NEXUS, LEEDS, LS2 3AA
Incorporated 18/04/2018

Compliance

Last accounts

31/05/2024

small

Next accounts due

28/02/2026

Overdue

Confirmation statement

Last: 17/04/2025

Due 01/05/2026

Overdue

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Professor Helen Philippou

director · Since 18/04/2018

SCIENTIST

BRITISH · ENGLAND · Age 58

Also on 1 other board

Dr Mary Eugenie Canning

director · Since 20/09/2019

COMPANY DIRECTOR

IRISH · UNITED KINGDOM · Age 52

Also on 3 other boards

Dr Peter Michael Finan

director · Since 20/09/2019

DIRECTOR

BRITISH · ENGLAND · Age 58

Also on 15 other boards

Mr Mervyn Turner

director · Since 04/10/2019

PRESIDENT, MJ TURNER CONSULTING, LLC

AMERICAN · UNITED STATES · Age 79

Persons with Significant Control

Epidarex Capital Iii Uk,Lp

25–50% shares
25–50% votes

137a, George Street, Edinburgh, EH2 4JY

Reg: Sl033678 · Companies House · Private Fund Limited Partnership

Notified 20/09/2019

Former PSCs

Caribou Property Ltd

Ceased 06/05/2020

Charges1 outstanding

Charge
outstanding

EPIDAREX CAPITAL III UK, LP AS LENDER

Created 06/11/2023Registered 08/11/2023

Insolvency History1 case

creditors voluntary liquidation13/05/2026

Elizabeth Aird-Brown (practitioner)

CompanyRankvs 34850+ SIC 72190 peers
30

Financial strength1th percentile among SIC peers · 0/25
Employees45th percentile among SIC peers · 7/15
LiquidityCurrent ratio 12.47× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10Insolvency history -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Insolvency history: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/05/2024

Net Worth

-£3.9M

Balance sheet strength

Cash

£775k

Cash in the bank

Net Current Assets

£776k

Working capital

Current Assets

£844k

Current Liabilities

£68k

Fixed Assets

£0

Debtors

£69k

1avg. employees

Balance Sheet

Assets less current liabilities£776k
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
202412.47-£318k
20230.25

Derived from filed accounts. Not audited figures.